Anthropic is the most frequent co-covered peer, appearing in 4 of the 12 tracked stories. That works out to roughly 0.5 stories per week across a 157-day span. The busiest single day carried 4. The clearest coverage concentration is earnings: 2 of 12 stories, with the rest divided among 8 other categories.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Clarivate Plc
Anthropic is the most frequent co-covered peer, appearing in 4 of the 12 tracked stories. That works out to roughly 0.5 stories per week across a 157-day span. The busiest single day carried 4. The clearest coverage concentration is earnings: 2 of 12 stories, with the rest divided among 8 other categories. Each carries 2.4 original sources on average. Negative sentiment appears in 0% of the tracked stories. Clarivate Plc appears in 12 tracked Cross-Sector stories published from February 26, 2026 through August 1, 2026.
Stories tracked
12
Per week
0.5
Negative
0%
Sources per story
2.4
Computed from the 12 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Clarivate Plc. Shared-story counts are live from our verified record — not editorial picks.
RiskMark’s CODiE win underscores the growing demand for cloud-based AI legal tools. Built on 172.5 million records, the SaaS product helps IP professionals run trademark analyses quickly, boosting Clarivate’s subscription revenue potential.
Clarivate’s RiskMark wins the CODiE Award for Best AI Tool for Lawyers, giving IP attorneys a tool that accelerates trademark clearance by analyzing 172.5 million records and 5 million court decisions in minutes, not hours.
The USPTO has deployed Clarivate’s AI image search capability in its public TM Search system, allowing users to compare uploaded images against the U.S. trademark register. The government contract validates Clarivate’s IP-focused AI and could set a precedent for other agencies to adopt similar SaaS tools. The move streamlines a historically manual process for over 600,000 annual trademark applicants.
Clarivate reports a 24% drop in total GHG emissions from a 2023 baseline, yet the self-reported press release lacks scope details and third-party verification. For climate watchers, this step signals intent but demands scrutiny on the path to science-based targets.
Clarivate has announced a strategic integration of its specialized regulatory intelligence into Anthropic’s Claude AI platform to streamline compliance for life sciences. This move combines high-fidelity proprietary data with advanced generative AI to reduce hallucinations in high-stakes regulatory workflows.
Clarivate has announced a strategic expansion that integrates its proprietary regulatory intelligence directly into Anthropic’s Claude AI platform. This move aims to provide life sciences and legal professionals with verified, real-time regulatory data to ground AI-generated insights and reduce hallucinations.
Clarivate Plc has expanded its strategic partnership with Anthropic to integrate its deep regulatory intelligence directly into the Claude AI platform. This integration provides life sciences and healthcare professionals with verified, real-time regulatory data to streamline drug development and market entry processes.
Clarivate Plc has announced a strategic expansion of its partnership with Anthropic to integrate its proprietary regulatory intelligence directly into the Claude AI platform. This move aims to provide legal and compliance professionals with grounded, authoritative data to minimize AI hallucinations in highly regulated sectors.
Leonardo DRS and Clarivate reported robust Q4 2025 results, highlighting a surge in demand for integrated defense electronics and AI-driven analytics. These results underscore a broader trend of increased technology spending in mission-critical sectors like national security and intellectual property management.
Leonardo DRS, Inc. reported a strong finish to 2025, buoyed by a record backlog and increased demand for maritime power systems. Meanwhile, Avanos Medical and Clarivate Plc showed resilient results as they navigate sector-specific restructuring and AI integration challenges.
Avanos Medical and Clarivate Plc reported Q4 2025 results highlighting a shift toward high-margin specialized medical devices and AI-driven life sciences analytics. Despite macroeconomic headwinds, these entities demonstrate a sector-wide pivot toward operational efficiency and data-centric healthcare solutions.
Leonardo DRS reported strong Q4 2025 performance, bolstered by critical wins in missile defense and a steady expansion of its naval propulsion business. The company's declaration of a $0.09 dividend reflects growing confidence in its long-term role within the U.S. Navy's submarine modernization programs.